High compared with standard dose lipase pancreatic supplement

P J Robinson; A Olinsky; A L Smith; S B Chitravanshi

doi:10.1136/adc.64.1.143

High compared with standard dose lipase pancreatic supplement

Arch Dis Child. 1989 Jan;64(1):143-5. doi: 10.1136/adc.64.1.143.

Authors

P J Robinson¹, A Olinsky, A L Smith, S B Chitravanshi

Affiliation

¹ Professorial Department of Thoracic Medicine, Royal Children's Hospital, Melbourne, Australia.

Abstract

Cotazym-S-Forte, a new pancreatic supplement containing 10,000 BP units of lipase activity per capsule, was compared with a standard dose pancreatin supplement (Pancrease) with 5000 BP units lipase activity in a randomised crossover trial. The number of capsules of Cotazym-S-Forte administered was half the usual number of Pancrease capsules and was associated with the same degree of fat absorption as Pancrease.

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Adolescent
Child
Child, Preschool
Clinical Trials as Topic
Cystic Fibrosis / drug therapy*
Cystic Fibrosis / metabolism
Delayed-Action Preparations
Dietary Fats / metabolism
Drug Administration Schedule
Female
Humans
Infant
Lipase / administration & dosage*
Male
Random Allocation

Substances

Delayed-Action Preparations
Dietary Fats
Lipase